Clear The Way – Don’t Jump the Gun: English Court of Appeal grants an Interim Injunction to AstraZeneca in Glenmark Dapagliflozin Case
In the UK, as well as in many other countries, being the first to market with a generic or biosimilar to a leading branded medicine is a critical strategy that can offer a major advantage to a company in a highly competitive landscape. Being the first company to launch a generic product has several advantages. …